Tech Company Financing Transactions

Zogenix Funding Round

On 9/23/2009, Zogenix received $51 million in Series B funding from Clarus, Domain Associates and Abingworth.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

5858 Horton St. 455
Emeryville, CA 94608
USA

Phone

(866) 964-3649

Website

www.zogenix.com

Email Address

[email protected]

Overview

Zogenix (NASDAQ: ZGNX) is a specialty pharmaceutical company whose goal is to uniquely enhance and differentiate medicines by incorporating innovative technologies in an effort to relieve suffering in people with CNS and pain disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stephen Farr

        

Chief Financial Officer

Michael Smith

        

Chief Medical Officer

Bradley Galer

        

VP - Bus. Development

Gail Farfel

        

VP - Bus. Development

Ashish Sagrolikar

        

Browse more venture capital transactions:

Prev: 9/23/2009: AppNexus venture capital transaction
Next: 9/23/2009: Micell Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary